ABM and InSphero Press Release
08/08/23
InSphero AG, the pioneer of 3D cell-based assay technology, today announced that the company is making their patented Akura™ Plate Technology available to researchers in the US market by signing a distribution agreement with Advanced BioMatrix, a leader in the life science of 3D applications for tissue culture, cell assay, bioprinting and cell proliferation.
InSphero, a global pioneer in 3D cell culture and organ-on-chip technology, is known for its Akura™ Plate Formats, engineered specifically for 3D cultures of spheroids and organoids, simplify aggregation and handling of spheroids and organoids and facilitates integration of 3D models into cell-based assay workflows providing researchers important advantages for their workflows:
“I am looking forward to expanding our range of applications for scientists and drug developers by combining ABM’s product range with the Akura™ Platform”, said Paul Clemencon, Head of Business Development of InSphero.” Combining ABM’s hydrogels with InSphero’s Akura™ Plates helps researchers working with scaffolds for their organoid and spheroid cultures to drive innovation in the pre-clinical drug discovery.
“The goal of Advanced BioMatrix is to provide innovative 3D matrices for breakthrough research. By combining the Akura™ spheroid and organoid platform with ABM biomaterials and hydrogels, we continue to expand available solutions and workflows for our customers,” said Bowman Bagley, CEO of Advanced BioMatrix. The ABM hydrogels focus on recreating an in vivo environment for cells, and the Akura™ platform supports this mission.
About Advanced BioMatrix
Advanced BioMatrix is a leader in the life science of three dimensional (3D) applications for tissue culture, cell assay, bioprinting and cell proliferation. Their products are recognized as the standard for purity, functionality and consistency. The company, located in the San Diego region – one of the world’s largest life science and biotechnology clusters, has been manufacturing and delivering high quality products for research uses and applications for over 10 years. Advanced BioMatrix is committed to “Transform science to a new level of discovery by providing advanced technologies through innovative 3D matrix products.”
About InSphero
InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug discovery in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow more effective, safe therapies to contact the clinic through superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to inspire the next generation of breakthrough therapies through customer obsession, commitment to innovation, and the model of excellence.
